Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis (Q39374455)

11 September 2017

Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis (English)

1 reference

11 September 2017

0 references

0 references

8

0 references

Martina Sauter

3

object named as

Martina Sauter

1 reference

11 September 2017

12

Reinhard Kandolf

1 reference

11 September 2017

14

Meinrad Gawaz

1 reference

11 September 2017

11

Boris Bigalke

1 reference

11 September 2017

1

Peter Seizer

1 reference

11 September 2017

10

Oliver Borst

1 reference

11 September 2017

Karin Klingel

2

1 reference

11 September 2017

Dirk Westermann

4

1 reference

11 September 2017

Carmen Ochmann

5

1 reference

11 September 2017

Tanja Schönberger

6

1 reference

11 September 2017

Rebecca Schleicher

7

1 reference

11 September 2017

Eva-Maria Schmidt

9

1 reference

11 September 2017

Harald Langer

13

1 reference

11 September 2017

Andreas E May

15

1 reference

11 September 2017

15 March 2012

1 reference

Journal of Molecular and Cellular Cardiology

11 September 2017

1 reference

11 September 2017

53

1 reference

11 September 2017

1

1 reference

11 September 2017

6-14

1 reference

Predictors of outcome in patients with suspected myocarditis

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

The role of chemokine receptors in primary, effector, and memory immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Extracellular cyclophilins contribute to the regulation of inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

SERCA2b activity is regulated by cyclophilins in human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Dealing with the family: CD147 interactions with cyclophilins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Targeting the chemotactic function of CD147 reduces collagen-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Cyclophilin A is a secreted growth factor induced by oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YJMCC.2012.03.004

1 reference

11 September 2017

1 reference